Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 140

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 140
---
ANCIAL STATEMENTS

(In
U. S. dollars, unless stated otherwise)

Note
4 - Reverse recapitalization

On
November 17, 2022, the Company consummated the Business Combination contemplated by the SPA between 8i, EHL, Watermark, and Kwong Yeow
Liew, dated April 11, 2022 and amended May 30, 2022, June 10, 2022, and September 7, 2022. As contemplated by the SPA, a business combination
between 8i and EHL was effected by the purchase by 8i of all of the issued and outstanding shares of EHL from Watermark, resulting in
EHL becoming a wholly owned subsidiary of 8i.

Upon
the consummation of the Business Combination, the following events contemplated by the SPA occurred, based on EUDA’s capitalization
as of November 17, 2022:

  all 1,500,000 issued and outstanding shares of EHL were converted into 14,000,000 shares of the Company’s no par value ordinary  
  the                                                                                                                              

  1,000,000 additional Earnout Shares to be issued if during the period beginning on the Closing Date and ending on the first anniversary of        
  1,000,000 additional Earnout Shares to be issued if during the period beginning on the first anniversary of the Closing Date and ending on        
  1,000,000 additional Earnout Shares to be issued if the consolidated audited financial statements of EUDA for the fiscal year commencing January  
  1,000,000 additional Earnout Shares to be issued if the consolidated audited financial statements of EUDA for the fiscal year commencing January  

In
connection with the closing the Business Combination:

  all                                                                                                                   
  all                                                                                                                   
  all                                                                                                                   

  all                                                                                                                                                                                 
  200,000 shares of the Company’s no par value ordinary shares were issued to a service provider in connection with the business combination;                                         
  60,000 shares of the Company’s no par value ordinary shares were issued to a service provider in connection with the closing of transactions                                        

EUDA
HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

(In
U. S. dollars, unless stated otherwise)

The
following table presents the number of the Company’s ordinary shares issued and outstanding immediately following the Reverse